NT5E and neoplasm: Within the tumor microenvironment, under hypoxic conditions, CD73-derived adenosine accumulates and potently suppresses T cell-mediated anti-tumor immune responses, mainly through stimulation of the cyclic AMP-elevating adenosine receptor A2A, reducing cytokines production, proliferation and cytotoxicity [17–22].